Positron emission tomography (PET) has greater temporal and spatial resolution. 
C
hronic heart failure remains a substantial cause of death and disability in Japan and the rest of the world (1) . Left ventricular dysfunction in ischemic heart failure is not always an irreversible process but can be improved significantly with recent optimal medical treatment, cardiac resynchronization therapy and invasive revascularization (2) . The coronary artery revascularization plays still most important role for improving survival and functional capacity in patients with ischemic heart disease. Reversible causes of left ventricular dysfunction in chronic ischemic heart failure patients can be identified by means of nuclear cardiology technique. While single photon emission computed tomography (SPECT) approach using Thallium 201 ( 201 Tl) and 99m Tc tracers has wildly contributed to provide information for identifying viable myocardium. 201 Tl retention in the myocardium reflects the cell membrane integrity of the Na/K pump. of both ischemia and viability.
18 F-FDG PET can predict improvement in heart failure symptoms, functional status, quality of life, and global and regional systolic function post revascularization (12) .
18 F-FDG PET is considered as an appropriate measure for viability assessment and, with some disagreement, for assessment of inducible ischemia as well.
The disagreement should be explained by the limited availability of PET around European countries, rather than by the value of the PET (12).
The role of viability assessment in ischemic heart failure patients is also discussed in Japanese circulation society (JCS)
guideline. Current JCS guidelines on nuclear cardiology tests gives the viability imaging of PET in patients with coronary artery disease a class I recommendation and level B of evidence (13 
